| Literature DB >> 33842216 |
Francesco Moscato1,2,3, Christoph Gross1,2, Martin Maw1,2,4, Thomas Schlöglhofer1,2,4, Marcus Granegger4, Daniel Zimpfer4, Heinrich Schima1,2,4.
Abstract
Technological progress of left ventricular assist devices (LVADs) towards rotary blood pumps and the optimization of medical management contributed to the significant improvements in patient survival as well as LVAD support duration. Even though LVAD therapy is now well-established for end-stage heart failure patients, the long-term occurrence of adverse events (AE) such as bleeding, infection or stroke, still represent a relevant burden. An early detection of AE, before onset of major symptoms, can lead to further optimization of patient treatment and thus mitigate the burden of AE. Continuous patient monitoring facilitates identification of pathophysiological states and allows anticipation of AE to improve patient management. In this paper, methods, algorithms and possibilities for continuous patient monitoring based on LVAD data are reviewed. While experience with continuous LVAD monitoring is currently limited to a few centers worldwide, the pace of developments in this field is fast and we expect these technologies to have a global impact on the well-being of LVAD patients. 2021 Annals of Cardiothoracic Surgery. All rights reserved.Entities:
Keywords: Left ventricular assist device (LVAD); adverse events (AE); hemodynamics; patient monitoring
Year: 2021 PMID: 33842216 PMCID: PMC8033254 DOI: 10.21037/acs-2020-cfmcs-218
Source DB: PubMed Journal: Ann Cardiothorac Surg ISSN: 2225-319X